EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology

Noelle E Gillis iD, Susan I Schmidt, Carol A Lange iD

Endocrinology · 06.11.2025 · 166 (12)

DOI: 10.1210/endocr/bqaf155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 23.10.2025. Verfasst von Noelle E Gillis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Progesterone, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tickle Family Land Grant Endowed Chair in Breast Cancer Research, Department of Defense, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progesterone receptor (PR) is a critical regulator of hormone signaling in breast tissue, with its 2 primary isoforms, PR-A and PR-B, exhibiting distinct and sometimes opposing functions. These isoforms arise from alternative promoter usage within the PGR gene, resulting in structural differences that influence their transcriptional activity, regulatory interactions, and post-translational modifications. This review explores the historical discovery of PR isoforms, their structural and functional differences, and the molecular mechanisms governing their transcriptional regulation. We also discuss their physiological roles in normal mammary gland development and how their dysregulation contributes to breast cancer progression, endocrine resistance, and cancer stem cell expansion. Understanding the distinct roles of PR isoforms in breast cancer biology holds significant implications for developing targeted therapeutic strategies aimed at modulating isoform-specific PR activity in hormone-driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, ProgesteroneSignal TransductionHumansFemaleProtein IsoformsAnimalsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

breast cancerprogesterone receptorssteroid hormonessteroid receptorstranscriptional regulation

Substanzen

Receptors, ProgesteroneProtein Isoforms

Autor:innen und Institutionen

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Microbiology, Immunology, and Cancer Biology Program, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.

ORCID-Profile: Noelle E Gillis, Carol A Lange

Förderung

  • Tickle Family Land Grant Endowed Chair in Breast Cancer Research
  • Department of Defense
  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gillis, N. E., Schmidt, S. I., & Lange, C. A. (2025). Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology. Endocrinology, 166(12). https://doi.org/10.1210/endocr/bqaf155

Vancouver

Gillis NE, Schmidt SI, Lange CA. Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology. Endocrinology. 2025;166(12). doi:10.1210/endocr/bqaf155

BibTeX
@article{Gillis2025,
  author = {Gillis, Noelle E and Schmidt, Susan I and Lange, Carol A},
  title = {Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology},
  journal = {Endocrinology},
  year = {2025},
  volume = {166},
  number = {12},
  doi = {10.1210/endocr/bqaf155}
}
Kostenlos starten →